Thursday, January 19, 2023 9:49:53 AM
Bid x Size
$271.06 x 1 Ask x Size $272.91 x 3
Volume 48,899
https://stockcharts.com/h-sc/ui?s=BGNE
BeiGene Says Brukinsa Gets UK Marketing Authorization for Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma
MT NEWSWIRES
08:38 AM EST, 01/19/2023 (MT Newswires) -- BeiGene (BGNE) said Thursday that the UK Medicines and Healthcare products Regulatory Agency has granted marketing authorizations for Brukinsa for the treatment of both chronic lymphocytic leukemia and marginal zone lymphoma.
(con't)
Recent BGNE News
- Targeting Cancer's Achilles Heel: AI-Driven DDR Therapies Offer Hope • AllPennyStocks.com • 09/17/2024 09:01:00 PM
- BeiGene Receives Israeli Ministry of Health Approval for TEVIMBRA® for the Treatment of Oesophageal Squamous Cell Carcinoma (OSCC) After Prior Chemotherapy • Business Wire • 09/17/2024 11:00:00 AM
- Tislelizumab, inibidor PD-1 da BeiGene, é aprovado no Brasil para o tratamento de carcinoma espinocelular de esôfago (ESCC) e câncer de pulmão de células não pequenas (NSCLC) • Business Wire • 09/16/2024 12:00:00 PM
- BeiGene präsentiert TEVIMBRA®-Daten bei Lungen- und Magen-Darm-Krebs auf dem ESMO 2024 • Business Wire • 09/10/2024 06:59:00 PM
- BeiGene présente les données de TEVIMBRA® sur les cancers pulmonaires et gastro-intestinaux au Congrès de l’ESMO 2024 • Business Wire • 09/10/2024 06:59:00 PM
- BeiGene annonce la mise à jour de la formation de son équipe de direction commerciale • Business Wire • 09/09/2024 06:52:00 PM
- BeiGene gibt Wechsel im kommerziellen Führungsteam bekannt • Business Wire • 09/09/2024 06:51:00 PM
- BeiGene Announces Updates to Commercial Leadership Team • Business Wire • 09/09/2024 11:00:00 AM
- BeiGene Highlights TEVIMBRA® Data in Lung and Gastrointestinal Cancers at ESMO 2024 • Business Wire • 09/09/2024 05:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2024 11:29:23 AM
- BeiGene to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference • Business Wire • 08/28/2024 10:01:00 AM
- BeiGene’s BGB-16673 Receives U.S. FDA Fast Track Designation for CLL/SLL • Business Wire • 08/26/2024 10:00:00 AM
- ベイジーン、2024年第2四半期決算および事業に関する最新情報を発表し、グローバル成長の次なる段階へ • Business Wire • 08/08/2024 08:46:00 PM
- BeiGene公布2024年第二季財務業績和公司最新情況,進入全球成長的新階段 • Business Wire • 08/08/2024 12:23:00 PM
- BeiGene startet mit der Bekanntgabe der Finanzergebnisse des zweiten Quartals 2024 und Unternehmens-Updates in die nächste Phase seines globalen Wachstums • Business Wire • 08/08/2024 12:22:00 PM
- BeiGene entame la prochaine phase de sa croissance mondiale en annonçant ses résultats financiers du deuxième trimestre 2024 et des nouvelles de l’entreprise • Business Wire • 08/08/2024 12:22:00 PM
- Form S-4 - Registration of securities, business combinations • Edgar (US Regulatory) • 08/07/2024 11:32:45 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 10:07:59 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 10:04:19 AM
- BeiGene Enters Next Phase of Global Growth with Announcement of Second Quarter 2024 Financial Results and Corporate Updates • Business Wire • 08/07/2024 10:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/30/2024 08:15:55 PM
- ベイジーン、米国に生物製剤製造および臨床研究開発の旗艦施設を開設し、世界のより多くの患者に医薬品を届けるためのグローバルな拡大を継続 • Business Wire • 07/23/2024 07:10:00 PM
- BeiGene設立美國旗艦生物製劑生產和臨床研發機構,繼續全球擴張,為全球更多病患提供藥品 • Business Wire • 07/23/2024 07:10:00 PM
- BeiGene inaugure un site phare de fabrication de produits biologiques et de R&D clinique aux États-Unis. La société poursuit également son expansion mondiale afin de proposer des médicaments à un plus grand nombre de patients dans le monde entier. • Business Wire • 07/23/2024 05:56:00 PM
- BeiGene eröffnet Flaggschiff-Anlage für Biologika-Herstellung und klinische Forschung und Entwicklung in den USA und setzt die globale Expansion fort, um mehr Patienten auf der ganzen Welt mit Medikamenten zu versorgen • Business Wire • 07/23/2024 05:56:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM